CBER Labeling Changes Related to Safety Findings that Used Real-World Evidence – FDA and Sponsor Conducted Studies

Summary

The FDA released guidance on the use of real-world data and real-world evidence in supporting regulatory decisions for biological products, including premarket evaluation and postmarket safety monitoring.